Pages that link to "Q44201659"
Jump to navigation
Jump to search
The following pages link to Aldosterone antagonist improves diastolic function in essential hypertension (Q44201659):
Displaying 32 items.
- Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects (Q21245671) (← links)
- Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic Review (Q26783958) (← links)
- Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia (Q30450624) (← links)
- Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts (Q33890276) (← links)
- Mineralocorticoid receptor antagonists and the metabolic syndrome (Q34168923) (← links)
- Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study (Q34586729) (← links)
- Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease (Q34997222) (← links)
- Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials (Q35018046) (← links)
- Novel pharmacological treatments for heart failure (Q35570949) (← links)
- Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system (Q35660795) (← links)
- Hypertensive heart disease: effects of lifestyle modifications and antihypertensive drug treatment (Q35821934) (← links)
- Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy (Q35938862) (← links)
- Diastolic heart failure in the elderly and the potential role of aldosterone antagonists (Q36491770) (← links)
- Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women (Q36761442) (← links)
- Diastolic dysfunction and atrial fibrillation (Q37081026) (← links)
- Blocking aldosterone in heart failure (Q37574673) (← links)
- Diagnosis and Management of Left Ventricular Diastolic Dysfunction in the Hypertensive Patient (Q37821746) (← links)
- Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults (Q37993133) (← links)
- Aldosterone receptor antagonists in cardiovascular disease: a review of the recent literature and insight into potential future indications. (Q38025063) (← links)
- Aldosterone receptor antagonists: current perspectives and therapies (Q38120241) (← links)
- Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents (Q38181208) (← links)
- Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease. (Q38658657) (← links)
- Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hyp (Q41348051) (← links)
- Effects of spironolactone in spontaneously hypertensive adult rats subjected to high salt intake (Q41826036) (← links)
- Upregulation of the Renin-Angiotensin-aldosterone-ouabain system in the brain is the core mechanism in the genesis of all types of hypertension (Q42176416) (← links)
- Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone (Q43630822) (← links)
- Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women (Q46974098) (← links)
- Emphasis on abdominal obesity as a modifier of eplerenone effect in heart failure: hypothesis-generating signals from EMPHASIS-HF. (Q47871190) (← links)
- The Role of the Mineralocorticoid Receptor in Inflammation: Focus on Kidney and Vasculature. (Q48025446) (← links)
- Mineralocorticoid receptor antagonist in heart failure: Past, present and future perspectives (Q49954326) (← links)
- Goals and guidelines for treating hypertension in a patient with heart failure (Q57308718) (← links)
- [Hypertensive heart disease and microangiopathy] (Q79314857) (← links)